166 related articles for article (PubMed ID: 17461896)
1. Factors determining adequacy of axillary node dissection in breast cancer patients.
Chagpar AB; Scoggins CR; Martin RC; Sahoo S; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
Breast J; 2007; 13(3):233-7. PubMed ID: 17461896
[TBL] [Abstract][Full Text] [Related]
2. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
Petrik DW; McCready DR; Sawka CA; Goel V
J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with surgical options for breast carcinoma.
Chagpar AB; Studts JL; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; McMasters KM
Cancer; 2006 Apr; 106(7):1462-6. PubMed ID: 16470610
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients.
Cil T; Hauspy J; Kahn H; Gardner S; Melnick W; Flynn C; Holloway CM
Ann Surg Oncol; 2008 Dec; 15(12):3361-8. PubMed ID: 18830666
[TBL] [Abstract][Full Text] [Related]
5. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
7. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
[TBL] [Abstract][Full Text] [Related]
8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
9. Surgeon and community factors affecting breast cancer sentinel lymph node biopsy.
Hutchinson JR; Chagpar AB; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM;
Am J Surg; 2005 Dec; 190(6):903-6. PubMed ID: 16307943
[TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node dissection in breast cancer: an evolving question?
Lagares-Garcia JA; Garguilo G; Kurek S; LeBlond G; Diaz F
Am Surg; 2000 Jan; 66(1):66-72. PubMed ID: 10651351
[TBL] [Abstract][Full Text] [Related]
11. Unnecessary axillary surgery for patients with node-negative breast cancer undergoing total mastectomy.
Olaya W; Morgan JW; Lum SS
Arch Surg; 2011 Sep; 146(9):1029-33. PubMed ID: 21930999
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
13. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of axillary staging using sentinel node biopsy or diagnostic axillary lymph node dissection--a case-control study.
Leidenius M; Krogerus L; Tukiainen E; von Smitten K
APMIS; 2004; 112(4-5):264-70. PubMed ID: 15233641
[TBL] [Abstract][Full Text] [Related]
15. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M
Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes.
Orr RK; Col NF; Kuntz KM
Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611
[TBL] [Abstract][Full Text] [Related]
19. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
[TBL] [Abstract][Full Text] [Related]
20. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]